Hematuria differential diagnosis: Difference between revisions
Line 17: | Line 17: | ||
| colspan="9" rowspan="1" style="background: #4479BA; color: #FFFFFF; text-align: center;" |'''Clinical manifestations''' | | colspan="9" rowspan="1" style="background: #4479BA; color: #FFFFFF; text-align: center;" |'''Clinical manifestations''' | ||
! colspan="2" rowspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Para-clinical findings | ! colspan="2" rowspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Para-clinical findings | ||
! | ! colspan="3" rowspan="5" |'''Gold standard''' | ||
|- | |- | ||
| colspan="6" rowspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |'''Symptoms''' | | colspan="6" rowspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |'''Symptoms''' | ||
! colspan="3" rowspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Physical examina | ! colspan="3" rowspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Physical examina | ||
|- | |- | ||
! rowspan="3" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Lab Findings | ! rowspan="3" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Lab Findings | ||
! rowspan="3" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Diagnosi | ! rowspan="3" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Diagnosi | ||
|- | |- | ||
! rowspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Low back pain | ! rowspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Low back pain | ||
Line 47: | Line 32: | ||
! rowspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Hypertension | ! rowspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Hypertension | ||
! colspan="1" rowspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Pitting edema | ! colspan="1" rowspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Pitting edema | ||
! rowspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Other | ! rowspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Other | ||
|- | |- | ||
Line 53: | Line 37: | ||
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Frequency | ! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Frequency | ||
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Oliguria | ! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Oliguria | ||
|- | |- | ||
| rowspan="7" style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Glomerular disease|Glomerular diseases]] | | rowspan="7" style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Glomerular disease|Glomerular diseases]] | ||
Line 69: | Line 51: | ||
| style="background: #F5F5F5; padding: 5px;" | - | | style="background: #F5F5F5; padding: 5px;" | - | ||
| style="background: #F5F5F5; padding: 5px;" | '''Biopsy:''' | | style="background: #F5F5F5; padding: 5px;" | '''Biopsy:''' | ||
IgA deposited in a diffuse granular patte | IgA deposited in a diffuse granular patte-rn in the mesangium | ||
| colspan="2" style="background: #F5F5F5; padding: 5px;" |Biopsy | |||
| | |||
* | * | ||
| style="background: #F5F5F5; padding: 5px;" | - | | style="background: #F5F5F5; padding: 5px;" | - | ||
|- | |- | ||
Line 99: | Line 75: | ||
| style="background: #F5F5F5; padding: 5px;" |'''Biopsy:''' | | style="background: #F5F5F5; padding: 5px;" |'''Biopsy:''' | ||
* Monoclonal antibodies directed against alpha-3 (IV), alpha-4 (IV), and alpha-5 (IV) chains of typ-e IV collagen | * Monoclonal antibodies directed against alpha-3 (IV), alpha-4 (IV), and alpha-5 (IV) chains of typ-e IV collagen | ||
| | | colspan="2" style="background: #F5F5F5; padding: 5px;" | | ||
* Genetic analysis | |||
* Genetic | |||
| style="background: #F5F5F5; padding: 5px;" | - | | style="background: #F5F5F5; padding: 5px;" | - | ||
|- | |- | ||
Line 131: | Line 101: | ||
* Immunoglobulin G and C3 in a diffuse granular pattern | * Immunoglobulin G and C3 in a diffuse granular pattern | ||
* Starr-y sky pattern | * Starr-y sky pattern | ||
| | | colspan="2" style="background: #F5F5F5; padding: 5px;" |Biopsy | ||
| style="background: #F5F5F5; padding: 5px;" | - | | style="background: #F5F5F5; padding: 5px;" | - | ||
|- | |- | ||
Line 162: | Line 127: | ||
* Segmental solidification in the perihilar region and peripheral areas, specially the tubular pole | * Segmental solidification in the perihilar region and peripheral areas, specially the tubular pole | ||
* Coarsely granular deposits -of IgM and C3 | * Coarsely granular deposits -of IgM and C3 | ||
| | | colspan="2" style="background: #F5F5F5; padding: 5px;" |Biopsy | ||
| style="background: #F5F5F5; padding: 5px;" | - | | style="background: #F5F5F5; padding: 5px;" | - | ||
|- | |- | ||
Line 195: | Line 154: | ||
| style="background: #F5F5F5; padding: 5px;" | Biopsy: | | style="background: #F5F5F5; padding: 5px;" | Biopsy: | ||
* Diffuse, proliferative, necrotizing glomerulonephritis with cresc-ent formation | * Diffuse, proliferative, necrotizing glomerulonephritis with cresc-ent formation | ||
| | | colspan="2" style="background: #F5F5F5; padding: 5px;" |Biopsy | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
|- | |- | ||
Line 222: | Line 177: | ||
| style="background: #F5F5F5; padding: 5px;" | Biopsy, | | style="background: #F5F5F5; padding: 5px;" | Biopsy, | ||
* Different pathologies, [[Lupus nephritis|CLICK HERE]] for more- information. | * Different pathologies, [[Lupus nephritis|CLICK HERE]] for more- information. | ||
| | | colspan="2" style="background: #F5F5F5; padding: 5px;" |Biopsy | ||
| style="background: #F5F5F5; padding: 5px;" | - | | style="background: #F5F5F5; padding: 5px;" | - | ||
|- | |- | ||
Line 243: | Line 194: | ||
* Proteinuria | * Proteinuria | ||
| style="background: #F5F5F5; padding: 5px;" | Biopsy | | style="background: #F5F5F5; padding: 5px;" | Biopsy | ||
| | | colspan="2" style="background: #F5F5F5; padding: 5px;" | Biopsy | ||
|- | |- | ||
! colspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Disease | ! colspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Disease | ||
Line 262: | Line 209: | ||
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Lab Findings | ! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Lab Findings | ||
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Diagnosis method | ! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Diagnosis method | ||
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Gold standard | ! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Gold standard | ||
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Additional findings | ! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Additional findings | ||
Line 285: | Line 229: | ||
* [[Edema]] and infiltration by mononuclear cells, (principally lymphocytes) | * [[Edema]] and infiltration by mononuclear cells, (principally lymphocytes) | ||
* [[Eosinophils]] are present, often in large numbers. | * [[Eosinophils]] are present, often in large numbers. | ||
| style="background: #F5F5F5; padding: 5px;" |Renal biopsy | | style="background: #F5F5F5; padding: 5px;" |Renal biopsy | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
Line 312: | Line 252: | ||
* Hydronephrosis +/- in sonography | * Hydronephrosis +/- in sonography | ||
* Abdominal CT scan without contrast | * Abdominal CT scan without contrast | ||
| style="background: #F5F5F5; padding: 5px;" |Abdominal Ct scan without contrast | |||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" |– | | style="background: #F5F5F5; padding: 5px;" |– | ||
|- | |- | ||
Line 341: | Line 278: | ||
* Biopsy: Kidney scar | * Biopsy: Kidney scar | ||
| style="background: #F5F5F5; padding: 5px;" |– | | style="background: #F5F5F5; padding: 5px;" |– | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
Line 366: | Line 300: | ||
* Both [[CT]] and [[MRI]] may be used to detect [[neoplastic]] masses that may define renal cell carcinoma or metastasis of the primary cancer. [[CT]] scan and use of intravenous (IV) contrast is generally used for work-up and follow-up of patients with [[Renal cell carcinoma|renal cell carcinom]]<nowiki/>a. | * Both [[CT]] and [[MRI]] may be used to detect [[neoplastic]] masses that may define renal cell carcinoma or metastasis of the primary cancer. [[CT]] scan and use of intravenous (IV) contrast is generally used for work-up and follow-up of patients with [[Renal cell carcinoma|renal cell carcinom]]<nowiki/>a. | ||
* The histological pattern of renal cell [[carcinoma]] depends whether it is [[Papillary|papillary,]] [[chromophobe]] or [[collecting duct]] renal cell carcinoma. | * The histological pattern of renal cell [[carcinoma]] depends whether it is [[Papillary|papillary,]] [[chromophobe]] or [[collecting duct]] renal cell carcinoma. | ||
| style="background: #F5F5F5; padding: 5px;" |– | | style="background: #F5F5F5; padding: 5px;" |– | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
Line 400: | Line 331: | ||
**[[Adipose tissue|Fat tissue]] | **[[Adipose tissue|Fat tissue]] | ||
**[[Fibrous connective tissue|Fibrous tissue.]] | **[[Fibrous connective tissue|Fibrous tissue.]] | ||
| style="background: #F5F5F5; padding: 5px;" |Biopsy | | style="background: #F5F5F5; padding: 5px;" |Biopsy | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
Line 430: | Line 348: | ||
* [[Hematuria]] | * [[Hematuria]] | ||
| style="background: #F5F5F5; padding: 5px;" |Ultrasound, CT scan, Biopsy | | style="background: #F5F5F5; padding: 5px;" |Ultrasound, CT scan, Biopsy | ||
| style="background: #F5F5F5; padding: 5px;" |Biopsy | | style="background: #F5F5F5; padding: 5px;" |Biopsy | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
Line 450: | Line 365: | ||
* [[Hematuria]] | * [[Hematuria]] | ||
| style="background: #F5F5F5; padding: 5px;" |Ultrasound, CT scan, Biopsy | | style="background: #F5F5F5; padding: 5px;" |Ultrasound, CT scan, Biopsy | ||
| style="background: #F5F5F5; padding: 5px;" |Biopsy | | style="background: #F5F5F5; padding: 5px;" |Biopsy | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
Line 469: | Line 381: | ||
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Lab Findings | ! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Lab Findings | ||
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Diagnosis method | ! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Diagnosis method | ||
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Gold standard | ! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Gold standard | ||
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Additional findings | ! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Additional findings | ||
Line 512: | Line 421: | ||
* Thickening and lamellation of tubular basement membranes | * Thickening and lamellation of tubular basement membranes | ||
* Microcysts | * Microcysts | ||
| style="background: #F5F5F5; padding: 5px;" |Ultrasound | | style="background: #F5F5F5; padding: 5px;" |Ultrasound | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
Line 541: | Line 446: | ||
* Ultrasound, | * Ultrasound, | ||
* Venography | * Venography | ||
| style="background: #F5F5F5; padding: 5px;" |'''Renal venography:''' Gold standard | | style="background: #F5F5F5; padding: 5px;" |'''Renal venography:''' Gold standard | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
Line 574: | Line 476: | ||
* Microthrombosis, and | * Microthrombosis, and | ||
* [[Degranulation]] of [[neutrophils]]. | * [[Degranulation]] of [[neutrophils]]. | ||
| style="background: #F5F5F5; padding: 5px;" |Biopsy | | style="background: #F5F5F5; padding: 5px;" |Biopsy | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
Line 604: | Line 499: | ||
IgA deposited in a diffuse granular pattern in the mesangium | IgA deposited in a diffuse granular pattern in the mesangium | ||
| style="background: #F5F5F5; padding: 5px;" |Renal biopsy, and clinical syndrome | | style="background: #F5F5F5; padding: 5px;" |Renal biopsy, and clinical syndrome | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
Line 623: | Line 515: | ||
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Lab Findings | ! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Lab Findings | ||
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Diagnosis method | ! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Diagnosis method | ||
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Gold standard | ! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Gold standard | ||
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Additional findings | ! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Additional findings | ||
Line 655: | Line 544: | ||
* Urine cytology to screen for bladder cancer | * Urine cytology to screen for bladder cancer | ||
* Biopsy to rule out cancer | * Biopsy to rule out cancer | ||
| style="background: #F5F5F5; padding: 5px;" |Biopsy | | style="background: #F5F5F5; padding: 5px;" |Biopsy | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
Line 667: | Line 552: | ||
| style="background: #F5F5F5; padding: 5px;" | + | | style="background: #F5F5F5; padding: 5px;" | + | ||
| style="background: #F5F5F5; padding: 5px;" | + | | style="background: #F5F5F5; padding: 5px;" | + | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
Line 681: | Line 563: | ||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Interstitial cystitis]] | | style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Interstitial cystitis]] | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
Line 699: | Line 578: | ||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Radiogenic|Radiogenic cystitis]] | | style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Radiogenic|Radiogenic cystitis]] | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
Line 718: | Line 594: | ||
| rowspan="5" style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Systemic diseases]] | | rowspan="5" style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Systemic diseases]] | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Hemophilia|Coagulopathy (hemophilia)]] | | style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Hemophilia|Coagulopathy (hemophilia)]] | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
Line 736: | Line 609: | ||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Sickle cell anemia]] | | style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Sickle cell anemia]] | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
Line 754: | Line 624: | ||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Abdominal aortic aneurysm]] | | style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Abdominal aortic aneurysm]] | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
Line 772: | Line 639: | ||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Lymphomas]] | | style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Lymphomas]] | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
Line 790: | Line 654: | ||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Multiple myeloma]] | | style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Multiple myeloma]] | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
Line 820: | Line 681: | ||
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Lab Findings | ! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Lab Findings | ||
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Diagnosis method | ! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Diagnosis method | ||
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Gold standard | ! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Gold standard | ||
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Additional findings | ! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Additional findings | ||
Line 847: | Line 705: | ||
* Hypodense appearance | * Hypodense appearance | ||
* [[Abscess|Abscesses]] may not be present | * [[Abscess|Abscesses]] may not be present | ||
| style="background: #F5F5F5; padding: 5px;" | - | | style="background: #F5F5F5; padding: 5px;" | - | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
Line 874: | Line 729: | ||
* Also help to detect the presence of a [[tumor]] or a [[Stone massage|stone]]. | * Also help to detect the presence of a [[tumor]] or a [[Stone massage|stone]]. | ||
| style="background: #F5F5F5; padding: 5px;" |Urine culture | | style="background: #F5F5F5; padding: 5px;" |Urine culture | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
Line 901: | Line 752: | ||
CT scan: | CT scan: | ||
* Edema of the [[prostate gland]] with diffuse enlargement,. | * Edema of the [[prostate gland]] with diffuse enlargement,. | ||
| style="background: #F5F5F5; padding: 5px;" | - | |||
| style="background: #F5F5F5; padding: 5px;" |- | |||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
|- | |- | ||
Line 926: | Line 774: | ||
* Diffuse, circumferential urothelial wall thickening and contrast-enhancement | * Diffuse, circumferential urothelial wall thickening and contrast-enhancement | ||
* Periureteric or perinephric fat stranding. | * Periureteric or perinephric fat stranding. | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
Line 941: | Line 786: | ||
| style="background: #F5F5F5; padding: 5px;" | - | | style="background: #F5F5F5; padding: 5px;" | - | ||
| style="background: #F5F5F5; padding: 5px;" | - | | style="background: #F5F5F5; padding: 5px;" | - | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
Line 952: | Line 794: | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Urogenital|Urogenital trauma]] | | style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Urogenital|Urogenital trauma]] | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Inserted [[bladder]] or [[Ureteral disease|ureteral catheters]] | | style="background: #DCDCDC; padding: 5px; text-align: center;" |Inserted [[bladder]] or [[Ureteral disease|ureteral catheters]] | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | |
Revision as of 16:57, 1 February 2019
Hematuria Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Hematuria differential diagnosis On the Web |
American Roentgen Ray Society Images of Hematuria differential diagnosis |
Risk calculators and risk factors for Hematuria differential diagnosis |
Steven C. Campbell, M.D., Ph.D. Associate Editor(s)-in-Chief: Omer Kamal, M.D.[1], Venkata Sivakrishna Kumar Pulivarthi M.B.B.S [2]
Overview
Gross hematuria(GH) must be distinguished from pigmenturia, which may be due to endogenous sources (e.g., bilirubin, myoglobin,and porphyrins), foods ingested (e.g., beets and rhubarb), drugs (e.g., phenazopyridine), and simple dehydration. This distinction can be made easily by urinalysis with microscopy. Notably, myoglobinuria and other factors can cause false-positive chemical tests for hemoglobin, so urine microscopy is required to confirm the diagnosis of hematuria. GH also must be distinguished from vaginal bleeding in women, which usually can be achieved by obtaining a careful menstrual history, collecting the specimen when the patient is not having menstrual or gynecologic bleeding, or, if necessary, obtaining a catheterized specimen. GH may also be detected by the presence of blood spotting on the undergarments of incontinent patients. After ruling out vaginal bleeding and mimics of hematuria, a urologic source must be suspected.
Differential Diagnosis
Hematuria should be differentiated from other disease which mimic hematuria especially hemoglobinuria and myoglobinuria which are dipstick positive but negative for microscopy.
Hematuria differential diagnosis
Differentiating the diseases that can cause hematuria:
Diseases | Clinical manifestations | Para-clinical findings | Gold standard | ||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Symptoms | Physical examina | ||||||||||||||
Lab Findings | Diagnosi | ||||||||||||||
Low back pain | Fever | Nausea/
Vomiting |
Urinary symptoms | Hypertension | Pitting edema | Other | |||||||||
Dysuria | Frequency | Oliguria | |||||||||||||
Glomerular diseases | IgA nephropathy (Berger nephropathy) | + | - | - | - | + | + | + | - | - | Biopsy:
IgA deposited in a diffuse granular patte-rn in the mesangium |
Biopsy
|
- | ||
Hereditary nephritis (Alport syndrome) | - | - | - | - | - | - | + | - |
|
Biopsy:
|
|
- | |||
Poststreptococcal glomerulonephritis | +/- | + | - | - | + | + | + | + |
|
|
Biopsy
|
Biopsy | - | ||
Focal segmental glomerular sclerosis | - | - | - | - | - | - | + | + |
|
|
Biopsy
|
Biopsy | - | ||
Rapidly progressive glomerulonephritis | + | + | + | - | - | - | + | - |
|
|
Biopsy:
|
Biopsy | |||
Lupus nephritis | - | + | - | - | - | - | + | + |
|
|
Biopsy,
|
Biopsy | - | ||
Fabry disease | - | - | - | - | - | - | + | + | - |
|
Biopsy | Biopsy | |||
Disease | Low back pain | Fever | Nausea/
Vomiting |
Dysuria | Frequency | Oliguria | Hypertension | Pitting edema | Other | Lab Findings | Diagnosis method | Gold standard | Additional findings | ||
Tubulointerstitial diseases | + | + | + | – | – | – | – | – | Rash | Biopsy:
|
Renal biopsy | ||||
Nephrolithiasis | + | ± | + | ± | ± | ± | – | – |
|
|
Abdominal Ct scan without contrast | – | |||
Reflux nephropathy (hydronephrosis) | + | + | - | - | - | - | - | + |
|
– | |||||
Malignancy | Renal cell carcinoma (RCC) | - | - | - | - | - | - | ± | ± |
|
|
|
– | ||
Nephroblastoma (Wilms tumor) | - | - | - | - | - | - | - | - |
|
Biopsy:
|
Biopsy | ||||
Bladder cancer | - | - | - | - | ± | ± | - | - | Suprapubic pain | Ultrasound, CT scan, Biopsy | Biopsy | ||||
Prostate cancer | ± | - | - | - | ± | ± | - | - | - | Ultrasound, CT scan, Biopsy | Biopsy | ||||
Disease | Low back pain | Fever | Nausea/
Vomiting |
Dysuria | Frequency | Oliguria | Hypertension | Pitting edema | Other | Lab Findings | Diagnosis method | Gold standard | Additional findings | ||
Familial diseases | Polycystic kidney disease | + | - | - | - | - | - | + | + |
|
Ultrasound:
CT:
Genetic testing demonstrates: Biopsy:
|
Ultrasound | |||
Vascular diseases | Renal vein thrombosis | + | + | + | - | - | - | - | - |
|
|
|
Renal venography: Gold standard | ||
Wegner's granulomatosis polyangiitis | - | - | - | - | - | +/- | + | + |
|
|
CT chest:
Biopsy:
|
Biopsy | |||
Henoch-Schönlein purpura | - | - | - | - | - | +/- | +/- | + |
|
|
Biopsy:
IgA deposited in a diffuse granular pattern in the mesangium |
Renal biopsy, and clinical syndrome | |||
Disease | Low back pain | Fever | Nausea/
Vomiting |
Dysuria | Frequency | Oliguria | Hypertension | Pitting edema | Other | Lab Findings | Diagnosis method | Gold standard | Additional findings | ||
Lower urinary tract diseases | Benign prostatic hyperplasia | +/- | - | - | + | + | - | - | - |
|
|
|
Biopsy | ||
Urolithiasis | + | +/- | + | + | |||||||||||
Interstitial cystitis | |||||||||||||||
Radiogenic cystitis | |||||||||||||||
Systemic diseases | Coagulopathy (hemophilia) | ||||||||||||||
Sickle cell anemia | |||||||||||||||
Abdominal aortic aneurysm | |||||||||||||||
Lymphomas | |||||||||||||||
Multiple myeloma | |||||||||||||||
Disease | Low back pain | Fever | Nausea/
Vomiting |
Dysuria | Frequency | Oliguria | Hypertension | Pitting edema | Other | Lab Findings | Diagnosis method | Gold standard | Additional findings | ||
Infectious diseases | Pyelonephritis | + | + | + | + | + | + | - | - |
|
CT and ultrasound: | - | |||
Cystitis | - | - | - | + | + | + | - | - |
|
|
|
Urine culture | |||
Prostatitis | - | + | - | + | + | + | - | - |
|
|
Ultrasound:
CT scan:
|
- | |||
Urethritis | -/- | + | - | + | + | + | - | - |
|
|
CT scan:
|
||||
Epididymitis | -/+ | + | + | - | - | - | - | - | |||||||
Urogenital trauma | Inserted bladder or ureteral catheters |
References
- ↑ Hartman DS, Sanders RC (April 1982). "Wilms' tumor versus neuroblastoma: usefulness of ultrasound in differentiation". J Ultrasound Med. 1 (3): 117–22. PMID 6152936.
- ↑ De Campo JF (1986). "Ultrasound of Wilms' tumor". Pediatr Radiol. 16 (1): 21–4. PMID 3003660.
- ↑ Cahan LD (1985). "Failure of encephalo-duro-arterio-synangiosis procedure in moyamoya disease". Pediatr Neurosci. 12 (1): 58–62. PMID 4080660.